The present invention relates to implantable medical devices and methods of manufacturing. More specifically, the invention relates to MRI compatible medical device lead and methods for manufacturing MRI compatible medical device lead.
Various medical devices are commonly used to treat patients suffering from chronic and/or disabling diseases such as chronic pain, Parkinson's disease, cardiac arrhythmias. Few of these medical devices are temporarily or permanently implanted within patient's body. Such medical devices include neurostimulators, cardiac pacemakers, or implantable cardioverter-defibrillators (ICDs) (collectively Implantable Medical Devices (IMDs)).
Generally, an IMD includes an implantable pulse generator and one or more conducting leads with electrodes used to conduct signals between the heart and the implantable pulse generator (IPG). Commonly, the IMD is implanted into the pectoral region of the patient's body. The leads extend from the IPG to stimulate one or more chambers of the heart. The leads are used to deliver therapy to the patient and each include one or more conducting cables, electrodes, and/or coils.
Further, in some scenarios, the patient with an IMD may need to undergo a Magnetic Resonance Imaging (MRI) scan. An MRI is a non-invasive imaging modality that utilizes a magnetic field and radio frequency (RF) pulses to generate images of various anatomical structures within a patient's body. Typically, an MRI scanner uses a magnet to create a strong static magnetic field to align the protons of hydrogen atoms in the patient's body. Then, the patient is exposed to RF pulses of electromagnetic energy causing the protons to spin about their axis. Once the RF pulses are removed, these protons tend to come back to their resting state aligned with the static magnetic field. The MRI scanner detects the signal generated by the spinning protons that is processed to create an image.
During the MRI scan, the RF pulses may be picked up by leads implanted within a patient's body. There is a need for improved lead design to minimize induced currents generated from MRI energy.
In Example 1, a medical device lead, comprising a lead body, an electrical conductor and a tubular conductive element. The lead body includes a tubular member having a proximal end, a distal end, and a conductor lumen extending therebetween, wherein the tubular member is made of an electrically insulative material. The electrical conductor extends within the conductor lumen from the proximal end of the tubular member toward the distal end of the tubular member. The tubular conductive element is disposed over the tubular member of the lead body between the proximal and distal ends thereof. The tubular conductive element has one or more kerfs formed therethrough so as to affect an electrical property thereof, and wherein the electrical conductor is electrically coupled to the tubular conductive element.
In Example 2, the medical device lead of Example 1, wherein the one or more kerfs are formed in a helical pattern such that electrical current passing through the tubular conductive element travels along a helical path.
In Example 3, the medical device lead of either of Examples 1 or 2, wherein the one or more kerfs have a constant pitch.
In Example 4, the medical device lead of either of Examples 1 or 2, wherein the one or more kerfs have a variable pitch.
In Example 5, the medical device lead of any of Examples 1-4, wherein the first segment defines an electrode of the medical device lead.
In Example 6, the medical device lead of any of Examples 1-5, wherein the tubular conductive element includes a first segment and a second segment extending distally from the first segment, wherein the one or more kerfs are formed in each of the first and second segments so as to affect an electrical property of the first and second segments, wherein the first segment has a higher electrical impedance than the second segment.
In Example 7, the medical device lead of Example 6, further comprising a layer of insulative material disposed over the first segment.
In Example 8. the medical device lead of either of Examples 6 or 7, wherein the first segment is operable to inhibit induced currents in the tubular conductive element in the presence of an external source of electromagnetic energy.
In Example 9, the medical device lead of any of Examples 1-5, wherein the tubular conductive element includes first, second and third segments, the second segment extending distally from the first segment, and the third segment extending distally from the second segment, wherein the one or more kerfs are formed in each of the first, second and third segments, and wherein the one or more kerfs in each of the first and second segments are configured so that the first and second segments have a higher electrical impedance than the third segment.
In Example 10, the medical device lead of Example 9, further comprising a layer of insulative material disposed over the first and second segments of the tubular conductive element, so that the first and second segments of the tubular conductive element are operable to inhibit induced currents in the tubular conductive element in the presence of an external source of electromagnetic energy.
In Example 11, the medical device lead of Example 10, wherein an outer surface of the third segment of the tubular conductive element is uninsulated so that the third segment can be operable as a shocking electrode.
In Example 12, the medical device lead of any of Examples 9-11, wherein the electrical conductor is mechanically and electrically coupled to the tubular conductive element at a connection location disposed at a transition between the first and second segments of the tubular conductive element.
In Example 13, the medical device lead of any of Examples 9-11, wherein the first, second and third segments are formed from a single tube of conductive material.
In Example 14, the medical device lead of any of Examples 9-11, wherein one or more of the first, second and third segments are formed from separate tubes of conductive material and subsequently joined together by a weld joint.
In Example 15, the medical device lead of any of Examples 9-14, wherein the kerfs in the third segment include a series of kerfs each extending partially circumferentially about the tubular conductive element and distributed along the length of the third segment, wherein each kerf in the third segment is circumferentially offset from adjacent kerfs so as to cause electrical current to assume a non-linear flow path through the third segment.
In Example 16, a medical device lead, comprising a lead body, an electrical conductor and a tubular conductive element. The lead body includes a tubular member having a proximal end and a distal end and a conductor lumen extending therebetween, wherein the tubular member is made of an electrically insulative material. The electrical conductor extends within the conductor lumen from the proximal end of the tubular member toward the distal end of the tubular member. The tubular conductive element is disposed over the tubular member of the lead body between the proximal and distal ends thereof. The tubular conductive element includes a first segment, a second segment extending distally from the first segment, and a third segment extending distally from the second segment, each of the segments having one or more kerfs formed radially therethrough in a predetermined configuration so as to affect an electrical impedance of the respective segment. The one or more kerfs in each of the first and second segments are configured so that the first and second segments have a higher electrical impedance than the third segment, and the electrical conductor is mechanically and electrically coupled to the tubular conductive element. A layer of insulative material is disposed over the first and second segments of the tubular conductive element. The first and second segments of the tubular conductive element are operable to inhibit induced currents in the tubular conductive element in the presence of an external source of electromagnetic energy. An outer surface of the third segment of the tubular conductive element is uninsulated so that the third segment can be operable as a shocking electrode.
In Example 17, the medical device lead of Example 16, wherein the electrical conductor is mechanically and electrically coupled to the tubular conductive element at a connection location disposed at a transition between the first and second segments of the tubular conductive element.
In Example 18, the medical device lead of either of Examples 16 or 17, wherein the kerfs in the first and second segments are formed in a helical pattern along a length thereof.
In Example 19, the medical device lead of any of Examples 16-18, wherein the kerfs in the first segment have a constant pitch along the length of the first segment.
In Example 20, the medical device lead of any of Examples 16-19, wherein the kerfs in the second segment have a constant pitch along the length of the second segment.
In Example 21, the medical device lead of any of Examples 16-18, wherein the kerfs in one or both of the first and second segments have a pitch that varies along the length of the respective segment.
In Example 22, the medical device lead of Example 21, wherein the pitch of the kerfs in one or both of the first and second segments decrease with distance from the connection location.
In Example 23, the medical device lead of any of Examples 16-22, wherein the kerfs in the third segment include a series of kerfs each extending partially circumferentially about the tubular conductive element and distributed along the length of the third segment, wherein each kerf in the third segment is circumferentially offset from adjacent kerfs so as to cause electrical current to assume a non-linear flow path through the third segment.
In Example 24, the medical device lead of any of Examples 16-23, wherein the first, second and third segments are formed from a single tube of conductive material.
In Example 25, the medical device lead of any of Examples 16-23, wherein one or more of the first, second and third segments are formed from separate tubes of conductive material and subsequently joined together by a weld joint.
In Example 26, a filtered electrode component for an implantable medical device lead, the filtered electrode component comprising a tubular conductive element including a first segment, a second segment extending distally from the first segment, and a third segment extending distally from the second segment, each of the segments having one or more kerfs formed radially therethrough in a predetermined configuration so as to affect an electrical impedance of the respective segment. The one or more kerfs in each of the first and second segments are configured so that the first and second segments have a higher electrical impedance than the third segment, and the tubular conductive element is configured to be mechanically and electrically coupled to an electrical conductor.
In Example 27, the filtered electrode component of Example 26, wherein the kerfs in the first and second segments are formed in a helical pattern along a length thereof.
In Example 28, the filtered electrode component of either of Examples 26 or 27, wherein the kerfs in one or both of the first and second segments has a constant pitch along the length of the respective segment.
In Example 29, the filtered electrode component of either of Examples 27 or 28, wherein the kerfs in one or both of the first and second segments have a pitch that varies along the length of the respective segment.
In Example 30, the filtered electrode component of Example 29, wherein the pitch of the kerfs in one or both of the first and second segments decreases with distance from the other of the first and second segments.
In Example 31, the filtered electrode component of any of Examples 26-30, wherein the kerfs in the third segment include a series of kerfs each extending partially circumferentially about the tubular conductive element and distributed along the length of the third segment, wherein each kerf in the third segment is circumferentially offset from adjacent kerfs so as to cause electrical current to assume a non-linear flow path through the third segment.
In Example 32, a method of forming an electrical component for a medical device lead, comprising mounting a tubular conductive element to a fixture, and cutting one or more kerfs radially through the tubular conductive element using a laser in one or more predetermined patterns configured so as to affect an electrical property of the tubular conductive element.
In Example 33, the method of Example 32, wherein cutting one or more kerfs includes cutting a first pattern of kerfs in a helical path along a first length of the tubular conductive element, and cutting a second pattern of kerfs in a non-helical pattern along a second length of the tubular conductive element.
In Example 34, the method of either of Examples 32 or 33, wherein cutting one or more kerfs includes cutting first, second and third patterns of kerfs to define first, second and third segments of the tubular conductive element, wherein the first and second patterns are helical patterns each having a variable pitch that decreases with distance from the other of the first and second patterns, and wherein the third pattern is a non-helical pattern, so that the first and second segments have an electrical impedance that is higher than an electrical impedance of the third segment.
In Example 35, the method of any of Examples 32-34, wherein the tubular conductive element is a first tubular conductive element, and wherein the method further comprises cutting one or more kerfs radially through a second tubular conductive element using a laser in one or more predetermined patterns configured so as to affect an electrical impedance of the second tubular conductive element, and mechanically and electrically joining the first and second tubular conductive elements.
While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.
In some embodiments, the lead 112 includes a lead body 117, a shocking electrode 118, a pacing/sensing electrode 120, and one or more conductors (not shown in
In the illustrated embodiment, the lead 112 is deployed in the right ventricle 104. However, in other embodiments, the lead 112 can be implanted in the right atrium 106 or both the right atrium 106 and the right ventricle 104, or a left chamber of the heart 102. In various embodiments, two or more leads 112 may be deployed within the heart 102 at different target regions.
The pulse generator 114 generally includes a power source and electronic circuitry configured to process and generate electrical signals. The power source includes a battery that provides power to the CRM system 100 to perform its operations. The electronic circuitry may include components for memory, processing, or the like. In some embodiments, the pulse generator 114 is implanted by forming a subcutaneous pocket in the pectoral girdle of the patient. Optionally, the pulse generator 114 can also be implanted in the thoracic cavity, abdominal region, neck region, or the like.
The following embodiments are primarily described in context of the CRM system 100. However, the skilled artisan will readily understand that the embodiments may also be used in conjunction with other implantable medical devices such as, but not limited to, deep brain stimulators, spinal cord stimulators, or the like.
More particularly, the lead body 117 includes an insulative tubular member 136 having a proximal end (not shown in
The first conductor lumen 140 is configured to receive the electrical conductor 126. In some embodiments, the electrical conductor 126 can be a high voltage cable or wire extending from the proximal end of the tubular member 136 towards the distal end 138. The electrical conductor 126 is configured to carry high voltage electrical signals from the pulse generator 114 to deliver shock to the heart 102 (see
In some embodiments, the tubular conductive element 130 is a tube like structure including a proximal segment 146, an intermediate segment 148, and a distal segment 150. In various embodiments, the proximal segment 146 and the intermediate segment 148 are operable to filter electromagnetic energy from an external source such as an MRI. The distal segment 150 is operable as a shocking electrode configured to deliver shock to the heart 102. The layer of insulative material 132 is disposed over the proximal segment 146 and the intermediate segment 148 such that these segments will not be able to deliver energy to surrounding tissue.
In various embodiments, the lead 112 may include two or more tubular conductive elements 130 disposed along its length, a distal tubular conductive element, and a proximal tubular conductive element. In an example, the distally located tubular conductive element is positioned within the right ventricle 104 and the proximally located tubular conductive element is positioned within the right atrium 106 or superior vena cava. The two tubular conductive elements may be independently activated based on the requirement of therapy.
The second conductor lumen 142 is configured to receive a conductor such as a low voltage conductor 128. In some embodiments, the low voltage conductor 128 extends to the tip electrode 134 at the distal end 138 of the insulative tubular member 136 of the lead body 117. In one embodiment, the low voltage conductor 128 can be in the form of a single- or multi-filar coil conductor. In various embodiments, the low voltage conductor 128 can be a non-coiled conductor (e.g., a multi-strand cable, or the like). The low voltage conductor 128 is configured to convey electrical signals from the heart 102, such as electrical activity of the heart 102, to the pulse generator 114 to detect abnormal rhythms. The low voltage conductor 128 may also transmit pacing signals from the pulse generator 114 to the heart 102. In various embodiments, the low voltage conductor 128 can be configured as a relatively high inductance coil to inhibit induced currents in the conductor. In some embodiments, the low voltage conductor 128 may define a lumen configured to receive a stylet or guide wire (not shown) for implanting the lead 112 within the patient's body.
The tip electrode 134 connected to the distal end of the low voltage conductor 128 is in contact with the tissue, such as heart tissue, for sensing electrical signals produced by the heart 102 and/or pacing the heart 102 by transmitting the pulses generated by the pulse generator 114. In some embodiments, the tip electrode 134 can be engaged with the tissue by active fixation such as a helix screw that can be inserted into the tissue by rotation of the helix screw. To accomplish rotation of the helix screw, the tip electrode 134 is mechanically coupled to the low voltage conductor 128, which in turn is mechanically coupled to a rotatable element (e.g., a terminal pin) at the proximal end of the lead. In such scenarios, the tip electrode 134 conducts as well as secures, the lead 112 to the cardiac tissue. In other embodiments, the tip electrode 134 can be passively engaged with the tissue just by contacting the tissue, such as a ring electrode, a ball shape electrode, or the like.
In some embodiments, the layer of insulative material 132 and the insulative tubular member 136 can be formed using a suitable electrically insulative biocompatible material such as, but not limited to, silicone, polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyvinylchloride (PVC), polyether-ester, polyamide, polyetheretherketone (PEEK), or the like. In some embodiments, the tubular member 136 and the conductor lumens 140, 142 have a circular cross-section. However, other suitable cross-sectional shapes may also be contemplated, such as but not limited to, rectangular, square, triangular, oval, or the like.
The proximal segment 146 includes a proximal end 152, a distal end 154, and a coiled conductor extending between the proximal end 152 and the distal end 154.
Referring to
The intermediate segment 148 is operable as an in-line tuning filter used to tune or choke the RF signals induced due to RF pulsating magnetic field or the MRI environment. The intermediate segment 148 has an inductance that poses high impedance to certain frequencies without affecting the flow of electrical signals generated by the pulse generator (such as pulse generator 114). When an alternating current is induced in the lead 112 due to RF signals, a magnetic field is generated around the intermediate segment 148 and this field opposes any further current changes. This enables the intermediate segment 148 to attenuate the undesired current or voltage signals generated within the lead 112 or the electrical conductor 126 such that the signals generated are not transmitted to other parts of the lead 112, particularly the shocking electrode. In some embodiments, the proximal segment 146 and the intermediate segment 148 may be tuned to different MRI frequencies such as 64 MHz, 128 MHz or other frequencies involved during MRI procedure.
In some embodiments, the proximal segment 146 and the intermediate segment 148 are configured and arranged to have kerfs formed in a helical pattern around the circumference and length of the tubular conductive element 130, such that the remaining conductive material also extends in a helical configuration. In various embodiments, the pitch (i.e., the distance between adjacent turns of the helically-arranged kerfs) can be substantially uniform along the length of the proximal and/or intermediate segments 146, 148. Alternatively, one or both of the proximal and distal segments 146, 150 can be configured such that the pitch(es) of the kerfs varies along all or part of the length of the segment. The variable pitch may alter the electrical properties of the proximal segment 146 and/or the intermediate segment 148. In one embodiment, the proximal segment 146 and the intermediate segment 148 are configured so as to have smaller pitch near the connection location 144.
The distal segment 150 forms a distal portion of the tubular conductive element 130. The distal segment 150 is operable as the shocking electrode configured to deliver shock or high voltage pulses to the heart. In the illustrated embodiment, the distal segment 150 is designed to have kerfs extending partially along the circumference of the tubular conductive element 130. When the electrical signal is sent to the distal segment 150, the kerfs direct the current to take a non-linear path distributing energy over a larger surface area, and thereby minimizing heating of surrounding tissue.
In various embodiments, the tubular conductive element 130 can be formed using a suitable non-ferromagnetic conducting biocompatible material such as, but not limited to, Nitinol™, gold, silver, stainless steel, copper, platinum, or a combination of these materials.
In some embodiments, a connector 256 (as shown in the detail view of
Additionally, as shown, the proximal segment 246 and the intermediate segment 248 have variable pitches. In some embodiments, the pitches of the kerfs in the proximal segment 246 and the intermediate segment 248 decrease in a direction away from the connection location 244 where the electrical conductor 226 is coupled to the tubular conductive element 230 to reduce reflection at the connection location 244.
Further, a laser 466 is deployed at a position over the tubular conductive element 430 mounted on the fixture 464. The laser 466 is configured to generate a high intensity light beam 468 and move axially in a transverse plane for cutting one or more kerfs 470 radially through the tubular conductive element 430. The laser 466 emits a high intensity beam of light that is made to fall on the tubular conductive element 430. The energy of the light beam 468 is transferred to the tubular conductive element 430, thereby melting and/or vaporizing the material of the tubular conductive element 430 and forming the kerfs 470. In some embodiments, the motion of the laser 466 can be controlled by an automated system causes the laser 466 output to follow a predetermined pattern.
In various embodiments, a CO2 laser is used to form the kerfs 470. Other suitable examples of the laser 466 that can be used to from the kerfs 470 include, but are not limited to, Nd-YAG laser, YAG laser, or the like. Alternatively, in some embodiments, plasma techniques may be employed to form kerfs 470 through the tubular conductive element 430.
In the various embodiments, the kerfs 470 can be formed so as to affect the electrical properties of the tubular conductive element 430. In some embodiments, a first pattern (not shown) of the kerfs 470 is cut along a first length of the tubular conductive material 430 and a second pattern of the kerfs 470 is cut along a second length of the tubular conductive element 430. The first pattern of the kerfs 470 includes a helical path formed along the first length, including the proximal segment and the intermediate segment. Further, in the illustrated embodiment, the second pattern of the kerfs 470 can include a helical pattern or a non-helical pattern along the second length. As shown, the non-helical pattern includes cuts or slots formed that extend partially along the circumference of the tubular conductive element 430.
In other embodiments, the kerfs 470 include a first pattern, a second pattern, and a third pattern of kerfs defined along different portions of the tubular conductive element 430. The first pattern defines a proximal segment (similar to proximal segment 146), a second pattern defines an intermediate segment (similar to intermediate segment 148), and a third pattern defines a distal segment (similar to distal segment 150) of the tubular conductive element 430. In a preferred embodiment, the first and the second patterns are helical patterns having a variable pitch. The variable pitch decreases with distance from the other of the first and second patterns. The third pattern is a non-helical pattern such that the proximal and intermediate segments have electrical impedances higher than the electrical impedance of the distal segment.
Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.
This application is a continuation of U.S. application Ser. No. 14/631,010, filed Feb. 25, 2015, now U.S. Pat. No. 9,504,821, which claims priority to Provisional Application No. 61/945,081, filed Feb. 26, 2014, all of which are herein incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3614692 | Rozelle et al. | Oct 1971 | A |
4131759 | Felkel | Dec 1978 | A |
4135518 | Dutcher | Jan 1979 | A |
4146036 | Dutcher et al. | Mar 1979 | A |
4209019 | Dutcher et al. | Jun 1980 | A |
4253462 | Dutcher et al. | Mar 1981 | A |
4350169 | Dutcher et al. | Sep 1982 | A |
4381013 | Dutcher | Apr 1983 | A |
4404125 | Abolins et al. | Sep 1983 | A |
4437474 | Peers-Trevarton | Mar 1984 | A |
4484586 | McMickle et al. | Nov 1984 | A |
4493329 | Crawford et al. | Jan 1985 | A |
4574800 | Peers-Trevarton | Mar 1986 | A |
4643202 | Roche | Feb 1987 | A |
4643203 | Labbe | Feb 1987 | A |
4649938 | McArthur | Mar 1987 | A |
4869970 | Gulla et al. | Sep 1989 | A |
5002067 | Berthelsen et al. | Mar 1991 | A |
5003975 | Hafelfinger et al. | Apr 1991 | A |
5020545 | Soukup | Jun 1991 | A |
5056516 | Spehr | Oct 1991 | A |
5074313 | Dahl et al. | Dec 1991 | A |
5144960 | Mehra et al. | Sep 1992 | A |
5201865 | Kuehn | Apr 1993 | A |
5217010 | Tsitlik et al. | Jun 1993 | A |
5222506 | Patrick et al. | Jun 1993 | A |
5231996 | Bardy et al. | Aug 1993 | A |
5241957 | Camps et al. | Sep 1993 | A |
5243911 | Dow et al. | Sep 1993 | A |
5246014 | Williams et al. | Sep 1993 | A |
5259395 | Li | Nov 1993 | A |
5300108 | Rebell et al. | Apr 1994 | A |
5324322 | Grill, Jr. et al. | Jun 1994 | A |
5330522 | Kreyenhagen | Jul 1994 | A |
5354327 | Smits | Oct 1994 | A |
5370666 | Lindberg et al. | Dec 1994 | A |
5378234 | Hammerslag et al. | Jan 1995 | A |
5387199 | Siman et al. | Feb 1995 | A |
5417208 | Winkler | May 1995 | A |
5425755 | Doan | Jun 1995 | A |
5456707 | Giele | Oct 1995 | A |
5476485 | Weinberg et al. | Dec 1995 | A |
5483022 | Mar | Jan 1996 | A |
5522872 | Hoff | Jun 1996 | A |
5522875 | Gates et al. | Jun 1996 | A |
5534018 | Wahlstrand et al. | Jul 1996 | A |
5542173 | Mar et al. | Aug 1996 | A |
5542174 | Chiu | Aug 1996 | A |
5545205 | Schulte et al. | Aug 1996 | A |
5549646 | Katz et al. | Aug 1996 | A |
5554139 | Okajima | Sep 1996 | A |
5574249 | Lindsay | Nov 1996 | A |
5584873 | Shoberg et al. | Dec 1996 | A |
5599576 | Opolski | Feb 1997 | A |
5609622 | Soukup et al. | Mar 1997 | A |
5618208 | Crouse et al. | Apr 1997 | A |
5649974 | Nelson et al. | Jul 1997 | A |
5658709 | Layman et al. | Aug 1997 | A |
5676694 | Boser et al. | Oct 1997 | A |
5693523 | Watanabe et al. | Dec 1997 | A |
5727552 | Ryan | Mar 1998 | A |
5727553 | Saad | Mar 1998 | A |
5728149 | Laske et al. | Mar 1998 | A |
5755742 | Schuelke et al. | May 1998 | A |
5760341 | Laske et al. | Jun 1998 | A |
5766227 | Nappholz et al. | Jun 1998 | A |
5800496 | Swoyer et al. | Sep 1998 | A |
5810887 | Accorti, Jr. et al. | Sep 1998 | A |
5817136 | Nappholz et al. | Oct 1998 | A |
5824026 | Diaz | Oct 1998 | A |
5833715 | Vachon et al. | Nov 1998 | A |
5849031 | Martinez et al. | Dec 1998 | A |
5891114 | Chien et al. | Apr 1999 | A |
5891179 | Er et al. | Apr 1999 | A |
5935159 | Cross, Jr. et al. | Aug 1999 | A |
5957966 | Schroeppel et al. | Sep 1999 | A |
5957970 | Shoberg et al. | Sep 1999 | A |
5968087 | Hess et al. | Oct 1999 | A |
6016447 | Juran et al. | Jan 2000 | A |
6057031 | Breme et al. | May 2000 | A |
6078840 | Stokes | Jun 2000 | A |
6083216 | Fischer, Sr. | Jul 2000 | A |
6101417 | Vogel et al. | Aug 2000 | A |
6106522 | Fleischman et al. | Aug 2000 | A |
6141593 | Patag | Oct 2000 | A |
6143013 | Samson et al. | Nov 2000 | A |
6178355 | Williams et al. | Jan 2001 | B1 |
6192280 | Sommer et al. | Feb 2001 | B1 |
6208881 | Champeau | Mar 2001 | B1 |
6249708 | Nelson et al. | Jun 2001 | B1 |
6256541 | Heil et al. | Jul 2001 | B1 |
6259954 | Conger et al. | Jul 2001 | B1 |
6289250 | Tsuboi et al. | Sep 2001 | B1 |
6295476 | Schaenzer | Sep 2001 | B1 |
6304784 | Allee et al. | Oct 2001 | B1 |
6317633 | Jorgenson et al. | Nov 2001 | B1 |
6356790 | Maguire | Mar 2002 | B1 |
6360129 | Ley et al. | Mar 2002 | B1 |
6400992 | Borgersen et al. | Jun 2002 | B1 |
6428537 | Swanson et al. | Aug 2002 | B1 |
6434430 | Borgersen et al. | Aug 2002 | B2 |
6456888 | Skinner et al. | Sep 2002 | B1 |
6493591 | Stokes | Dec 2002 | B1 |
6501991 | Honeck et al. | Dec 2002 | B1 |
6501994 | Janke et al. | Dec 2002 | B1 |
6510345 | Van Bentem | Jan 2003 | B1 |
6516230 | Williams et al. | Feb 2003 | B2 |
6526321 | Spehr | Feb 2003 | B1 |
6564107 | Bodner et al. | May 2003 | B1 |
6671554 | Gibson et al. | Dec 2003 | B2 |
6701191 | Schell | Mar 2004 | B2 |
6721600 | Jorgenson et al. | Apr 2004 | B2 |
6721604 | Robinson et al. | Apr 2004 | B1 |
6813251 | Garney et al. | Nov 2004 | B1 |
6813521 | Bischoff et al. | Nov 2004 | B2 |
6850803 | Jimenez et al. | Feb 2005 | B1 |
6854994 | Stein et al. | Feb 2005 | B2 |
6866044 | Bardy et al. | Mar 2005 | B2 |
6906256 | Wang | Jun 2005 | B1 |
6909256 | Itabashi | Jun 2005 | B2 |
6920361 | Williams | Jul 2005 | B2 |
6925334 | Salys | Aug 2005 | B1 |
6944489 | Zeijlemaker et al. | Sep 2005 | B2 |
6949929 | Gray et al. | Sep 2005 | B2 |
6978185 | Osypka | Dec 2005 | B2 |
6985755 | Cadieux et al. | Jan 2006 | B2 |
6985775 | Rinke et al. | Jan 2006 | B2 |
6993373 | Vrijheid et al. | Jan 2006 | B2 |
6999818 | Stevenson et al. | Feb 2006 | B2 |
6999821 | Jenney et al. | Feb 2006 | B2 |
7013180 | Dublin et al. | Mar 2006 | B2 |
7013182 | Krishnan | Mar 2006 | B1 |
7047075 | Stubbs | May 2006 | B2 |
7047083 | Gunderson et al. | May 2006 | B2 |
7050855 | Zeijlemaker et al. | May 2006 | B2 |
7113827 | Silvestri et al. | Sep 2006 | B2 |
7123013 | Gray | Oct 2006 | B2 |
7127294 | Wang et al. | Oct 2006 | B1 |
7135978 | Gisselberg et al. | Nov 2006 | B2 |
7138582 | Lessar et al. | Nov 2006 | B2 |
7158837 | Osypka et al. | Jan 2007 | B2 |
7174219 | Wahlstrand et al. | Feb 2007 | B2 |
7174220 | Chitre et al. | Feb 2007 | B1 |
7205768 | Schulz et al. | Apr 2007 | B2 |
7239916 | Thompson et al. | Jul 2007 | B2 |
7242987 | Holleman et al. | Jul 2007 | B2 |
7257449 | Bodner | Aug 2007 | B2 |
7289851 | Gunderson et al. | Oct 2007 | B2 |
7363090 | Halperin et al. | Apr 2008 | B2 |
7369898 | Kroll et al. | May 2008 | B1 |
7378931 | Odahara et al. | May 2008 | B2 |
7388378 | Gray et al. | Jun 2008 | B2 |
7389148 | Morgan | Jun 2008 | B1 |
7453344 | Maeda et al. | Nov 2008 | B2 |
7535363 | Gisselberg et al. | May 2009 | B2 |
7571010 | Zarembo et al. | Aug 2009 | B2 |
7584005 | Jain | Sep 2009 | B1 |
7610101 | Wedan et al. | Oct 2009 | B2 |
7630761 | Salo et al. | Dec 2009 | B2 |
7689291 | Polkinghorne et al. | Mar 2010 | B2 |
7765005 | Stevenson | Jul 2010 | B2 |
7853332 | Olsen et al. | Dec 2010 | B2 |
7877150 | Hoegh et al. | Jan 2011 | B2 |
7912552 | Przybyszewski | Mar 2011 | B2 |
7917213 | Bulkes et al. | Mar 2011 | B2 |
7933662 | Marshall et al. | Apr 2011 | B2 |
7953499 | Knapp et al. | May 2011 | B2 |
7986999 | Wedan et al. | Jul 2011 | B2 |
7991484 | Sengupta et al. | Aug 2011 | B1 |
8000801 | Stevenson et al. | Aug 2011 | B2 |
8027736 | Wahlstrand et al. | Sep 2011 | B2 |
8032230 | Cox et al. | Oct 2011 | B1 |
8046084 | Bodner | Oct 2011 | B2 |
8099177 | Dahlberg | Jan 2012 | B2 |
8103360 | Foster | Jan 2012 | B2 |
8108054 | Helland | Jan 2012 | B2 |
8145324 | Stevenson et al. | Mar 2012 | B1 |
8170688 | Wedan et al. | May 2012 | B2 |
8200342 | Stevenson et al. | Jun 2012 | B2 |
8214055 | Erickson | Jul 2012 | B2 |
8244346 | Foster et al. | Aug 2012 | B2 |
8255055 | Ameri | Aug 2012 | B2 |
8306630 | Stubbs et al. | Nov 2012 | B2 |
8315715 | Erickson | Nov 2012 | B2 |
8332050 | Perrey et al. | Dec 2012 | B2 |
8335572 | Ameri | Dec 2012 | B2 |
8369964 | Ameri | Feb 2013 | B2 |
8391994 | Foster et al. | Mar 2013 | B2 |
8401671 | Wedan et al. | Mar 2013 | B2 |
8406895 | Erbstoeszer et al. | Mar 2013 | B2 |
8543209 | Tyers et al. | Sep 2013 | B2 |
8543218 | Erickson | Sep 2013 | B2 |
8666508 | Foster et al. | Mar 2014 | B2 |
8666512 | Walker et al. | Mar 2014 | B2 |
8670828 | Hall et al. | Mar 2014 | B2 |
8670840 | Wedan et al. | Mar 2014 | B2 |
8676344 | Desai et al. | Mar 2014 | B2 |
8676351 | Foster et al. | Mar 2014 | B2 |
8682451 | Wengreen et al. | Mar 2014 | B2 |
8688236 | Foster | Apr 2014 | B2 |
8731685 | Ameri | May 2014 | B2 |
8744600 | Perrey et al. | Jun 2014 | B2 |
8798767 | Foster et al. | Aug 2014 | B2 |
8825179 | Walker et al. | Sep 2014 | B2 |
8825181 | Foster et al. | Sep 2014 | B2 |
8954168 | Foster | Feb 2015 | B2 |
8983623 | Foster et al. | Mar 2015 | B2 |
9050457 | Foster et al. | Jun 2015 | B2 |
9199077 | Foster et al. | Dec 2015 | B2 |
9203648 | Shraim et al. | Dec 2015 | B2 |
9254380 | Ameri et al. | Feb 2016 | B2 |
9504822 | Foster | Nov 2016 | B2 |
20020065544 | Smits | May 2002 | A1 |
20020072769 | Silvian et al. | Jun 2002 | A1 |
20020111664 | Bartig et al. | Aug 2002 | A1 |
20020128689 | Connelly et al. | Sep 2002 | A1 |
20020144720 | Zahorik et al. | Oct 2002 | A1 |
20030028231 | Partridge et al. | Feb 2003 | A1 |
20030050680 | Gibson et al. | Mar 2003 | A1 |
20030063946 | Williams et al. | Apr 2003 | A1 |
20030083723 | Wilkinson et al. | May 2003 | A1 |
20030083726 | Zeijlemaker et al. | May 2003 | A1 |
20030092303 | Osypka | May 2003 | A1 |
20030093136 | Osypka et al. | May 2003 | A1 |
20030093138 | Osypka et al. | May 2003 | A1 |
20030139794 | Jenney et al. | Jul 2003 | A1 |
20030140931 | Zeijlemaker et al. | Jul 2003 | A1 |
20030144705 | Funke | Jul 2003 | A1 |
20030144716 | Reinke et al. | Jul 2003 | A1 |
20030144718 | Zeijlemaker | Jul 2003 | A1 |
20030144719 | Zeijlemaker | Jul 2003 | A1 |
20030144720 | Villaseca et al. | Jul 2003 | A1 |
20030144721 | Villaseca et al. | Jul 2003 | A1 |
20030204217 | Greatbatch | Oct 2003 | A1 |
20040014355 | Osypka et al. | Jan 2004 | A1 |
20040064161 | Gunderson et al. | Apr 2004 | A1 |
20040064173 | Hine et al. | Apr 2004 | A1 |
20040064174 | Belden | Apr 2004 | A1 |
20040088033 | Smits et al. | May 2004 | A1 |
20040097965 | Gardeski et al. | May 2004 | A1 |
20040122490 | Reinke et al. | Jun 2004 | A1 |
20040153049 | Hewitt et al. | Aug 2004 | A1 |
20040162600 | Williams | Aug 2004 | A1 |
20040167442 | Shireman et al. | Aug 2004 | A1 |
20040172117 | Hill et al. | Sep 2004 | A1 |
20040193140 | Griffin et al. | Sep 2004 | A1 |
20040243210 | Morgan et al. | Dec 2004 | A1 |
20040267107 | Lessar et al. | Dec 2004 | A1 |
20050030322 | Gardos | Feb 2005 | A1 |
20050070972 | Wahlstrand et al. | Mar 2005 | A1 |
20050090886 | MacDonald et al. | Apr 2005 | A1 |
20050113873 | Weiner et al. | May 2005 | A1 |
20050113876 | Weiner et al. | May 2005 | A1 |
20050136385 | Mann et al. | Jun 2005 | A1 |
20050149169 | Wang et al. | Jul 2005 | A1 |
20050177135 | Hildebrand et al. | Aug 2005 | A1 |
20050182471 | Wang | Aug 2005 | A1 |
20050197677 | Stevenson | Sep 2005 | A1 |
20050222642 | Przybyszewski et al. | Oct 2005 | A1 |
20050222656 | Wahlstrand et al. | Oct 2005 | A1 |
20050222657 | Wahlstrand et al. | Oct 2005 | A1 |
20050222658 | Hoegh et al. | Oct 2005 | A1 |
20050222659 | Olsen et al. | Oct 2005 | A1 |
20050227398 | Anderson et al. | Oct 2005 | A1 |
20050246007 | Sommer et al. | Nov 2005 | A1 |
20050267556 | Shuros et al. | Dec 2005 | A1 |
20050272280 | Osypka | Dec 2005 | A1 |
20050283167 | Gray | Dec 2005 | A1 |
20060009819 | Przybyszewski | Jan 2006 | A1 |
20060030774 | Gray et al. | Feb 2006 | A1 |
20060037461 | Yasumura | Feb 2006 | A1 |
20060041293 | Mehdizadeh et al. | Feb 2006 | A1 |
20060041294 | Gray | Feb 2006 | A1 |
20060041296 | Bauer et al. | Feb 2006 | A1 |
20060089691 | Kaplan et al. | Apr 2006 | A1 |
20060089695 | Bolea et al. | Apr 2006 | A1 |
20060089696 | Olsen et al. | Apr 2006 | A1 |
20060093685 | Mower et al. | May 2006 | A1 |
20060105066 | Teague et al. | May 2006 | A1 |
20060106442 | Richardson et al. | May 2006 | A1 |
20060118758 | Wang et al. | Jun 2006 | A1 |
20060129043 | Ben-Jacob et al. | Jun 2006 | A1 |
20060167536 | Nygren et al. | Jul 2006 | A1 |
20060200218 | Wahlstrand | Sep 2006 | A1 |
20060229693 | Bauer et al. | Oct 2006 | A1 |
20060247747 | Olsen et al. | Nov 2006 | A1 |
20060247748 | Wahlstrand et al. | Nov 2006 | A1 |
20060252314 | Atalar et al. | Nov 2006 | A1 |
20060253180 | Zarembo et al. | Nov 2006 | A1 |
20060271138 | MacDonald | Nov 2006 | A1 |
20060293737 | Krishnan | Dec 2006 | A1 |
20070010702 | Wang et al. | Jan 2007 | A1 |
20070027532 | Wang et al. | Feb 2007 | A1 |
20070055317 | Stahmann et al. | Mar 2007 | A1 |
20070106332 | Denker et al. | May 2007 | A1 |
20070112398 | Stevenson et al. | May 2007 | A1 |
20070156205 | Larson et al. | Jul 2007 | A1 |
20070179577 | Marshall et al. | Aug 2007 | A1 |
20070179582 | Marshall et al. | Aug 2007 | A1 |
20070191914 | Stessman | Aug 2007 | A1 |
20070208383 | Williams | Sep 2007 | A1 |
20070255317 | Fanton et al. | Nov 2007 | A1 |
20070255378 | Polkinghorne et al. | Nov 2007 | A1 |
20080009905 | Zeijlemaker | Jan 2008 | A1 |
20080033497 | Bulkes et al. | Feb 2008 | A1 |
20080039709 | Karmarkar | Feb 2008 | A1 |
20080049376 | Stevenson et al. | Feb 2008 | A1 |
20080051854 | Bulkes et al. | Feb 2008 | A1 |
20080057784 | Zarembo et al. | Mar 2008 | A1 |
20080058902 | Gray et al. | Mar 2008 | A1 |
20080119917 | Geistert | May 2008 | A1 |
20080125754 | Beer et al. | May 2008 | A1 |
20080129435 | Gray | Jun 2008 | A1 |
20080132985 | Wedan et al. | Jun 2008 | A1 |
20080132986 | Gray et al. | Jun 2008 | A1 |
20080140152 | Imran et al. | Jun 2008 | A1 |
20080154348 | Atalar et al. | Jun 2008 | A1 |
20080208290 | Phillips et al. | Aug 2008 | A1 |
20080243218 | Bottomley et al. | Oct 2008 | A1 |
20080262584 | Bottomley et al. | Oct 2008 | A1 |
20080269831 | Erickson | Oct 2008 | A1 |
20090005825 | MacDonald | Jan 2009 | A1 |
20090024180 | Kisker et al. | Jan 2009 | A1 |
20090024197 | Jensen | Jan 2009 | A1 |
20090099440 | Viohl | Apr 2009 | A1 |
20090099555 | Viohl et al. | Apr 2009 | A1 |
20090118610 | Karmarkar et al. | May 2009 | A1 |
20090149920 | Li et al. | Jun 2009 | A1 |
20090149933 | Ameri | Jun 2009 | A1 |
20090149934 | Ameri et al. | Jun 2009 | A1 |
20090198314 | Foster et al. | Aug 2009 | A1 |
20090204171 | Ameri | Aug 2009 | A1 |
20090210022 | Powers | Aug 2009 | A1 |
20090270948 | Nghiem et al. | Oct 2009 | A1 |
20090270956 | Vase et al. | Oct 2009 | A1 |
20090281608 | Foster | Nov 2009 | A1 |
20100010602 | Wedan et al. | Jan 2010 | A1 |
20100016935 | Strandberg et al. | Jan 2010 | A1 |
20100049290 | Min et al. | Feb 2010 | A1 |
20100103215 | Iriguchi | Apr 2010 | A1 |
20100106215 | Stubbs et al. | Apr 2010 | A1 |
20100114277 | Zhao et al. | May 2010 | A1 |
20100125320 | Polkinghorne et al. | May 2010 | A1 |
20100137928 | Duncan et al. | Jun 2010 | A1 |
20100174348 | Bulkes et al. | Jul 2010 | A1 |
20100174349 | Stevenson et al. | Jul 2010 | A1 |
20100234929 | Scheuermann | Sep 2010 | A1 |
20100249892 | Bulkes et al. | Sep 2010 | A1 |
20100292744 | Hill et al. | Nov 2010 | A1 |
20100331936 | Perrey et al. | Dec 2010 | A1 |
20110060394 | Poore | Mar 2011 | A1 |
20110079423 | Zhao et al. | Apr 2011 | A1 |
20110087299 | Ameri | Apr 2011 | A1 |
20110087302 | Ameri | Apr 2011 | A1 |
20110093054 | Ameri | Apr 2011 | A1 |
20110160805 | Erbstoeszer et al. | Jun 2011 | A1 |
20110160816 | Stubbs et al. | Jun 2011 | A1 |
20110160817 | Foster et al. | Jun 2011 | A1 |
20110160818 | Struve | Jun 2011 | A1 |
20110160828 | Foster et al. | Jun 2011 | A1 |
20110160829 | Foster et al. | Jun 2011 | A1 |
20110208280 | Li et al. | Aug 2011 | A1 |
20110218422 | Atalar et al. | Sep 2011 | A1 |
20110238146 | Wedan et al. | Sep 2011 | A1 |
20110288403 | Kondabatni et al. | Nov 2011 | A1 |
20120016451 | Struve et al. | Jan 2012 | A1 |
20120022356 | Olsen et al. | Jan 2012 | A1 |
20120035698 | Johnson et al. | Feb 2012 | A1 |
20120053662 | Foster et al. | Mar 2012 | A1 |
20120101558 | Kampa et al. | Apr 2012 | A1 |
20120109270 | Foster | May 2012 | A1 |
20120143273 | Stubbs et al. | Jun 2012 | A1 |
20120161901 | Stevenson et al. | Jun 2012 | A1 |
20120179233 | Wedan et al. | Jul 2012 | A1 |
20120232609 | Tyers et al. | Sep 2012 | A1 |
20120253340 | Stevenson et al. | Oct 2012 | A1 |
20120271394 | Foster et al. | Oct 2012 | A1 |
20130116764 | Walker et al. | May 2013 | A1 |
20130123884 | Ameri | May 2013 | A1 |
20130158641 | Foster et al. | Jun 2013 | A1 |
20130190849 | Perrey et al. | Jul 2013 | A1 |
20130190850 | Wedan et al. | Jul 2013 | A1 |
20130282093 | Walker et al. | Oct 2013 | A1 |
20130325093 | Foster | Dec 2013 | A1 |
20140067030 | Walker et al. | Mar 2014 | A1 |
20140114383 | Foster et al. | Apr 2014 | A1 |
20140155972 | Foster et al. | Jun 2014 | A1 |
20140324139 | Foster et al. | Oct 2014 | A1 |
20150105846 | Foster | Apr 2015 | A1 |
20150182744 | Foster et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
1154833 | Oct 1983 | CA |
1762510 | Apr 2006 | CN |
1905789 | Jan 2007 | CN |
101039619 | Sep 2007 | CN |
101553165 | Oct 2009 | CN |
102186534 | Sep 2011 | CN |
102209575 | Oct 2011 | CN |
104736196 | Jun 2015 | CN |
0897997 | Feb 2003 | EP |
1594564 | Nov 2005 | EP |
1852810 | Nov 2007 | EP |
2445577 | May 2012 | EP |
2227289 | Jul 2015 | EP |
2890446 | Jul 2015 | EP |
2908903 | Aug 2015 | EP |
H0747139 | Feb 1995 | JP |
2001522631 | Nov 2001 | JP |
2004511293 | Apr 2004 | JP |
2004141679 | May 2004 | JP |
2005501673 | Jan 2005 | JP |
2005515852 | Jun 2005 | JP |
2005515854 | Jun 2005 | JP |
2005522301 | Jul 2005 | JP |
2007520254 | Jul 2007 | JP |
2011504405 | Feb 2011 | JP |
2011509813 | Mar 2011 | JP |
2015520007 | Jul 2015 | JP |
WO9606655 | Mar 1996 | WO |
WO9923958 | May 1999 | WO |
WO0232325 | Apr 2002 | WO |
WO03063946 | Aug 2003 | WO |
WO03063953 | Aug 2003 | WO |
WO03089045 | Oct 2003 | WO |
WO2004073791 | Sep 2004 | WO |
WO2005030322 | Apr 2005 | WO |
WO2006105066 | Mar 2006 | WO |
WO2006093685 | Sep 2006 | WO |
WO2007047966 | Apr 2007 | WO |
WO2007089986 | Aug 2007 | WO |
WO2007118194 | Oct 2007 | WO |
WO2008051122 | May 2008 | WO |
WO2009100003 | Aug 2009 | WO |
WO20090137186 | Nov 2009 | WO |
WO2010078552 | Jul 2010 | WO |
2011081713 | Jul 2011 | WO |
2012038378 | Mar 2012 | WO |
2014066010 | May 2014 | WO |
Entry |
---|
International Preliminary Report on Patentability issued in PCT/US2015/017473, mailed Sep. 9, 2016, 8 pages. |
International Search Report and Written Opinion issued in PCT/US2013/065517, mailed Dec. 20, 2013, 11 pgs. |
“High Voltage Engineering and Testing, 2nd Edition”, edited by Hugh M. Ryan, Institution of Engineering and Technology, 2001, 15 pages. |
Avalanche Breakdown, Wikipedia Article, captured Apr. 6, 2010, [http://en.wikipedia.org/wiki/Avalanche—breakdown]. |
Basso, Christophe, “SPICE Model Simulates Spark-Gap Arrestor”, Electronics Design, Strategy, and News (EDN), Jul. 3, 1997, 4 pages. |
Citel Inc., Data Sheet, BH Series 2 Electrode Miniature Gas Discharge Tube Surge Arrester—8mm, May 14, 2009, 2 pages. |
File History for U.S. Appl. No. 11/015,807, filed Dec. 17, 2004 to Cooke, Daniel J. et al. |
Gray, Robert W. et al., “Simple design changes to wires to substantially reduce MRI-induced heating at 1.5 T: implications for implanted leads”, Magnetic Resonance Imaging 23 (2005) 887-891. |
Hayes, David L., Chapter 4, “Generator and Lead Selection” from book entitled “Cardiac Pacing and Defibrillation a Clinical Approach”, John Wiley & Sons, (c) 2000 Mayo Foundation, p. 129-157. |
International Preliminary Examination Report issued in PCT/US2013/065517, completed Apr. 21, 2015, 8 pages. |
International Search Report and Written Opinion issued in PCT/US2008/085518 on Oct. 29, 2009, 15 pages. |
International Search Report and Written Opinion issued in PCT/US2009/032838, mailed May 4, 2009, 14 pages. |
International Search Report and Written Opinion issued in PCT/US2009/038629, mailed Jun. 29, 2009, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2009/056843, mailed Dec. 29, 2009, 13 pages. |
International Search Report and Written Opinion issued in PCT/US2010/024062, mailed Sep. 27, 2010. |
International Search Report and Written Opinion issued in PCT/US2010/033686 on Aug. 10, 2010, 12 pages. |
International Search Report and Written Opinion issued in PCT/US2010/048620, mailed Apr. 5, 2011, 10 pages. |
International Search Report and Written Opinion issued in PCT/US2010/053223, mailed Dec. 27, 2010, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2010/055130, mailed Mar. 10, 2011, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2010/055653, mailed Feb. 1, 2011, 14 pages. |
International Search Report and Written Opinion issued in PCT/US2011/052541, dated Mar. 9, 2012, 22 pages. |
International Search Report and Written Opinion issued in PCT/US2012/055673, mailed Dec. 13, 2012, 10 pages. |
International Search Report and Written Opinion issued in PCT/US2013/037432, mailed Nov. 19, 2013, 17 pages. |
International Search Report and Written Opinion issued in PCT/US2013/057732, mailed Dec. 13, 2013, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2015/017473, mailed May 20, 2015, 10 pages. |
Invitation to Pay Additional Fees and Partial Search Report, dated Aug. 17, 2009, issued in PCT/US2008/085533, 6 pages. |
Invitation to Pay Additional Fees and Partial Search Report, issued in PCT/US2010/024062, mailed May 7, 2010. |
Partial International Search Report issued in PCT/US2011/052541, mailed Dec. 6, 2011, 4 pages. |
Partial International Search Report issued in PCT/US2013/013432, mailed Jul. 17, 2013, 6 pages. |
Partial International Search Report issued in PCT/US2013/037432, mailed Jul. 17, 2013, 6 pages. |
Static Spark Gap Analysis, captured Dec. 24, 2002, [http://www.richieburnett.co.uk/static.html]. |
Third Party Submission Under 37 CFR 1.290 filed in U.S. Appl. No. 14/056,746 on May 20, 2014, 13 pages. |
Number | Date | Country | |
---|---|---|---|
20160361538 A1 | Dec 2016 | US |
Number | Date | Country | |
---|---|---|---|
61945081 | Feb 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14631010 | Feb 2015 | US |
Child | 15245600 | US |